Basal growth hormone concentrations in blood and the risk for prostate cancer: A case-control study

Abstract

Lower basal levels of GH in serum are associated with increased prostate cancer risk. The inverse association may be explained by the negative feedback loop generated by IGF-1 produced by the tumor on GH secretion.